A study of 20vPnC vaccine in healthy children – if it was safe and produced antibody responses against a germ called Streptococcus pneumoniae
A study of 20vPnC vaccine in healthy children – if it was safe and produced antibody responses against a germ called Streptococcus pneumoniae. A Phase 3, Single-Arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through 17 Years of Age.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT04642079
Protocol ID: B7471014
PrintDownloadOpen Plain Language Summary Result: Click here